Restoring the intestinal barrier in inflammatory diseases

vignete

About Us

We are committed to the development of non-immunosuppressive small molecule therapies for treatment of inflammatory diseases

Our world class team has 2 decades of intestinal epithelial barrier expertise combined with a track record of success spanning over 35 INDs and 6 commercial products

Team

Miro Brajenovic, PhD


Chief Executive Officer

Roman Sakowicz, PhD


Chief Technology Officer, Head of Discovery

Vallen Graham, PhD


Co-founder, Head of Research

Petr Jansa, PhD


Head of Medicinal Chemistry

Nargis Kohgadai


Associate Scientist

Naomi Vinod


Research Associate intern

Scientific Advisory Board

Bruce Sands, MD


Clinical Advisor

Stefan Schreiber, MD, PhD


Clinical Advisor

Careers

  • Research Associate

  • Senior Research Associate

  • Scientist/Senior Scientist

Contact